10 Posts Not to Miss from EHA 2025
The European Hematology Association (EHA) Congress 2025 is officially underway in Milan. From June 12 to 15, hematology professionals from around the world are gathering to share the latest research, clinical advances, and innovations shaping the future of hematologic care.
EHA 2025 features a comprehensive scientific program that includes high-level plenary sessions, oral abstract presentations, clinical and translational research highlights, and disease-specific updates across malignant and non-malignant hematologic conditions. With hundreds of abstracts presented, as well as interactive education sessions and collaborative forums, the congress offers unparalleled insight into evolving standards of care, novel therapies, and mechanisms of disease.
This year’s meeting also celebrates the 30th edition of the EHA Congress, a milestone reflecting three decades of scientific excellence, global collaboration, and commitment to improving outcomes for patients with blood disorders. The program places a strong emphasis on innovation, equity, and mentorship, highlighted by prestigious award recognitions honoring leaders in the field.
Our team at OncoDaily has handpicked 10 highlights from the firts day of EHA 2025. Scroll down to catch the highlights, dive into the science, and hear directly from the people shaping the future of cancer care.


at EHA 2025 in between sessions !”



“Very productive first meeting with my mentee Thanks European Hematology Association for this mentorship program.”





To stay on top of everything happening at EHA 2025, keep following Hemostasis Today.
Written by Nare Hovhannisyan, MD
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference
-
Oct 19, 2026, 10:27Heather M. Johnson: Join the Discussion on Optimizing the CTEPH Diagnostic Pathway
-
Oct 19, 2026, 10:18Flora Peyvandi: Unravelling the Complexity of VWF Through Genetics
-
Oct 19, 2026, 09:55High DOAC Adherence in Patients With Ischemic Stroke and AF – International Journal of Stroke